TITLE

TOP STORIES

PUB. DATE
October 2007
SOURCE
MondayMorning;10/1/2007, Vol. 15 Issue 39, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that U.S. President George W. Bush signed legislation that gives the U.S. more power to police the safety of prescription drugs. The legislation is a response by Congress to concern that regulators have not acted against harmful medications. It also grants the Food and Drug Administration (FDA) authority to make pharmaceutical companies study the safety of their products after they go to market.
ACCESSION #
26909965

 

Related Articles

  • TOP STORIES.  // MondayMorning;9/24/2007, Vol. 15 Issue 38, p1 

    The article reports that the U.S. Congress has sent U.S. President George W. Bush legislation which provides the government with more power to police the safety of prescription drugs. The legislation grants the Food and Drug Administration (FDA) authority to make pharmaceutical companies study...

  • As I See It. Dickinson, James G. // Medical Marketing & Media;Feb2005, Vol. 40 Issue 2, p16 

    The author in this article reports that U.S. President George W. Bush's second term doesn't look to be as good for pharmaceutical marketers as his first--which might have been much better than it was, but for the economic downturn after September 11, 2001. One bright spot could be product...

  • New Law to Improve Animal Drug Review.  // FDA Consumer;Jan/Feb2004, Vol. 38 Issue 1, p5 

    Reports on a legislation signed by U.S. President George W. Bush in November 2003 that will provide user fees to the U.S. Food and Drug Administration (FDA) for animal drug reviews. Aim of the legislation; Estimated budget that will be allotted to FDA starting 2004.

  • HHS: PDUFA Reauthorization Good for Americans.  // FDA Consumer;Sep/Oct2002, Vol. 36 Issue 5, p5 

    Reports that U.S. President George W. Bush signed into law the reauthorization of the Prescription Drug User Fee Act (PDUFA). Collection of fees; Access to more resources for the U.S. Food and Drug Administration (FDA); Views of Health and Human Services Secretary Tommy G. Thompson; Ability to...

  • THE BEST PHARMACEUTICALS FOR CHILDREN ACT OF 2002: THE RISE OF THE VOLUNTARY INCENTIVE STRUCTURE AND CONGRESSIONAL REFUSAL TO REQUIRE PEDIATRIC TESTING. Breslow, Lauren Hammer // Harvard Journal on Legislation;Winter2003, Vol. 40 Issue 2, p133 

    On January 4, 2002, President Bush signed into law the Best Pharmaceuticals for Children Act, which is the government's most comprehensive legislation regarding pediatric research to date. The Act offers pharmaceutical companies a six-month exclusivity term in return for their agreement to...

  • IBWA Corner: President signs food registry bill; dental caries study released.  // Water Technology;Dec2007, Vol. 30 Issue 12, p44 

    The article reports on bill signed into law by U.S. President George W. Bush which reauthorizes user fees for prescription drugs and medical devices, as well as provisions on food safety. The most dramatic change to the food safety law in HR 3580 is the establishment of a food registry. The Food...

  • BUSH ADMINISTRATION TORT REFORM PROPOSALS. Getty, J. Paul // Electronic Ardell Wellness Report (E-AWR);5/6/2005, Issue 282, p12 

    The article focuses on the proposals by President George W. Bush administration' reform efforts. When drug companies are sued for complications arising from previously unknown adverse product side effects, the situation seems quite unfair, in that the company jumped all the hoops required to...

  • As I See It. Dickinson, James G. // Medical Marketing & Media;Apr2008, Vol. 43 Issue 4, p16 

    The author reflects on the need for U.S. President George W. Bush's administration to settle product liability issues in the pharmaceutical industry. He claims that their failure to address the issue would give the Democratic administration an opportunity to reverse Republicans' previous...

  • Independents rally against Bush discount card. Hollon, Thomas // Drug Topics;6/17/2002, Vol. 146 Issue 12, p47 

    Argues against the Medicare drug discount program by the administration of U.S. President George W. Bush. Implications of the program for community pharmacies; Benefits of the program to senior citizens; Introduction of a bill that allows pharmacies to reimport drugs made in the U.S.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics